High Outcome-Reporting Bias in Randomized-Controlled Trials of Acupuncture for Cancer Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Epidemiological Study.

Acupuncture has been explored as a natural way to help cancer patients manage nausea and vomiting caused by chemotherapy — two of the most distressing side effects of cancer treatment. Many patients turn to acupuncture hoping to reduce these symptoms and improve their quality of life during an already difficult time. But how reliable is the research supporting this use?

A new systematic review published in Current Oncology took a close look at 11 clinical trials on acupuncture for chemotherapy-induced nausea and vomiting, published between 1987 and 2019. Rather than measuring whether acupuncture worked, the researchers examined whether the studies themselves were conducted and reported honestly and transparently.

What they found was concerning. Only 4 out of 11 studies (36%) had been registered in a clinical trial registry before the research began — a standard practice that helps ensure researchers report all their findings, not just the positive ones. Of those four, only two were registered prospectively, meaning before the study started, which is the gold standard for trustworthy research.

The review also found that in several studies, the outcomes that were actually reported didn't fully match what the researchers originally planned to measure. This is called selective outcome-reporting bias, and it's a problem because it can make a treatment appear more effective than it really is.

What does this mean for you as a patient? It means that while acupuncture may offer real benefits for chemotherapy-related nausea, the current body of evidence has significant quality gaps that make it hard to know for certain. The science needs to catch up with better-designed and more transparently reported studies.

If you're considering acupuncture during cancer treatment, speak with your oncology team and seek care from a licensed, experienced acupuncturist who specializes in oncology support.

This meta-epidemiological systematic review assessed selective outcome-reporting bias across 11 RCTs (published 1987–2019) examining acupuncture for chemotherapy-induced nausea and vomiting (CINV). Investigators evaluated trial registry availability, registry validity, and outcome concordance using a seven-domain outcome classification framework (type, domain, specific measurement, metric, data type, aggregation method, and timepoint).

Key findings: Only 4 of 11 trials (36%) were registered, with only 2 meeting prospective registration criteria. No study reported complete outcomes as pre-specified in their protocol. Discrepancies were identified in outcome measurement tools and specific metrics across multiple studies, with many additional discrepancies deemed non-evaluable due to insufficient protocol detail.

No effect sizes were meta-analyzed, as the study focused exclusively on methodological integrity rather than clinical efficacy. Clinical takeaway: Practitioners citing acupuncture-for-CINV literature should apply caution, as pervasive outcome-reporting bias substantially limits the validity of existing evidence. Prospective trial registration with granular outcome pre-specification is critically needed in oncology acupuncture research.